O The BSH changes its view of the drug it directed, scientists review the controversial study

The authors of the important study said that their research has resulted in the fact that hydrochloric medicine increases the death risks of coronary patients treated with antimalarch have revised their research. Review published in “Lancet” and comes just two days after the medical magazine published the drug concern. Along with the publication, more [...]
Review published in “Lancet” and comes just two days after the medical magazine published the drug concern.
Along with the publication, more than 120 prominent scientists raised questions about the data used in the study, coming from a private company-led database, “Surgisphere”.
On this study, international drug tests were cut off, though some in the United States continued. President Donald Trump himself declared that he took the drug he called a turning point in hopes of preventing infection.











